Lexaria received independent review board approval for its HYPER-H21-4 human clinical study for hypertension treatment The stage is also set…
SRAX's performance goes from strength to strength; company announced revenue guidance expecting revenues of $11.5 million for the first quarter…
Over 466 million people current suffer from disabling hearing loss with a further 1.1 billion people at risk of suffering…
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in…
President and CTO Dean Rositano was invited to be a new member of the prestigious Rolling Stone Culture Council –…
PlantX Life (CSE: VEGA) (OTCQB: PLTXF) (Frankfurt: WNT1) today announced the launch of its new YouTube series entitled “Medically Speaking,”…
Playgon Games (TSX.V: DEAL) (OTCQB: PLGNF) (FRA: 7CR) is a propriety software-as-a-service (“SaaS”) technology company delivering mobile live dealer technology…
Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of innovative, broadly enabling, pressure-based instruments, consumables and…
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, aims to set itself apart from the rest of the…
Cybin (NYSE American: CYBN) (NEO: CYBN), a life sciences company advancing psychedelic therapeutics for various psychiatric and neurological conditions, recently…